News of Note—Japanese robotics company Riverfield bags $10M; Abbott earns CE mark for next-gen stent

News of note

> Japanese robotics player Riverfield scored 1.15 billion yen ($10.1 million) in new financing to fuel its mission to undercut Intuitive Surgical. Nikkei Asian Review article

> Abbott received a CE mark for its next-generation drug-eluting stent, the Xience Sierra. Improvements include better flexibility, a thinner profile and smaller diameters. Drug Delivery Business News article

> The Chinese FDA approved Allergan’s eye implant for the treatment of macular edema that follows branch retinal vein occlusion or central retinal vein occlusion. Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.

Precision oncology firm Notable Labs is launching its first self-sponsored clinical trial, designed from the ground up to help validate its platform.